TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2131900

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of diphenhydramine 30 minutes prior to heparin administration (Group II)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 5 mg/kg of cimetidine 4 hours and again 30 minutes before heparin administration (Group III)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of diphenhydramine 30 minutes prior to heparin administration and 5 mg/kg of cimetidine 4 hours and 30 minutes before heparin administration (Group IV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No histamine-receptor blockade (Group I - Control)
Number of subjects: 200
Study: 388988

Group type: EXPERIMENTAL
Intervention: Lofepramine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 46
Study: 31519267

Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Simple Touch
Number of subjects: 380
Study: 28456442

Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pregabalin 300mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 25701335

Group type: EXPERIMENTAL
Intervention: Legume-enriched diet
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Legume-enriched diet (women subgroup)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 26
Study: 23289899

Group type: EXPERIMENTAL
Intervention: NWP06 (extended-release methylphenidate)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 21298377

Group type: EXPERIMENTAL
Intervention: Expression of p53, Ki-67 and c-Myc proteins in adjacent non-neoplastic mucosa
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Expression of p53, Ki-67 and c-Myc proteins in surgical margin mucosa
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Molecular markers (p53, Ki-67, c-Myc) for assessing surgical margin status
Number of subjects: 154
Study: 19239556

Group type: EXPERIMENTAL
Intervention: Rosmarinic acid (0.3%) emulsion applied topically twice a day (morning and evening)
Number of subjects: 21
Study: 15925737

Group type: EXPERIMENTAL
Intervention: Flavonoid-rich dark chocolate (100 g)
Number of subjects: 17
Study: 12181083

Group type: EXPERIMENTAL
Intervention: huperzine Alpha 400 micro g/day for 12 weeks
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: huperzine Alpha
Number of subjects: 202
Study: 10506234

Group type: EXPERIMENTAL
Intervention: Cefadroxil
Number of subjects: 462

Group type: COMPARATOR
Intervention: Penicillin V
Number of subjects: 462
Study: 7594027

Group type: EXPERIMENTAL
Intervention: Arbutamine stress thallium-201 SPECT
Number of subjects: 184

Group type: COMPARATOR
Intervention: Exercise stress thallium-201 SPECT
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Arbutamine and exercise stress testing
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Arbutamine
Number of subjects: 184
Study: 2016620

Group type: EXPERIMENTAL
Intervention: Intravenous human recombinant interferon beta (rIFN‐beta; Betaseron) given by IV infusion over 30 minutes 3 times per week (MWF) with dose escalation: 50-100-200, 100-200-400, 200-300-500, and 300-400-600 x 10(6) IU/m2.
Number of subjects: 29
Study: 7326374

Group type: EXPERIMENTAL
Intervention: Specially designed prenatal care process or service (Groups 1 and 2)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard midwifery care and continuity of caregiver (Groups 3 and 4)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No continuity of caregiver or special treatment (Group 4)
Number of subjects: 108
Study: 29952247

Group type: EXPERIMENTAL
Intervention: HIIT (3 × 30‐s maximal cycle ergometer sprints against a resistance of 7.5% body weight, interspersed with 2 min of active recovery)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 40
Study: 27902891

Group type: EXPERIMENTAL
Intervention: Computerized agility training in barefoot footwear
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Computerized agility training in minimal footwear
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Computerized agility training in traditional shoes
Number of subjects: 30
Study: 26629989

Group type: EXPERIMENTAL
Intervention: Angled split virtual keyboard
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard virtual keyboard
Number of subjects: 18

Group type: COMPARATOR
Intervention: Wide virtual keyboard
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Usage position in bed
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Typing sessions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Body discomfort rating
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Split keyboard design
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Wide keyboard
Number of subjects: 18
Study: 24557963

Group type: EXPERIMENTAL
Intervention: Enteral nutrition plus polyethylene glycol (Group 2)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Enteral nutrition plus magnesium sulfate (Group 4)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Polyethylene glycol (Group 1)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Magnesium sulfate (Group 3)
Number of subjects: 108
Study: 21291943

Group type: EXPERIMENTAL
Intervention: Topiramate (100-200 mg/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 18928481

Group type: EXPERIMENTAL
Intervention: Nesiritide (NES) 72-hour infusion at 0.01 mcg/kg/min
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nesiritide (NES)
Number of subjects: 19
Study: 16609069

Group type: EXPERIMENTAL
Intervention: Intrathecal triple therapy (MTX, cytarabine, and hydrocortisone sodium succinate)
Number of subjects: 2027

Group type: COMPARATOR
Intervention: Intrathecal methotrexate
Number of subjects: 2027
Study: 14743074

Group type: EXPERIMENTAL
Intervention: Mail-in specimen submission option
Number of subjects: 122

Group type: COMPARATOR
Intervention: Clinic rescreening
Number of subjects: 122
Study: 11471407

Group type: EXPERIMENTAL
Intervention: Modified positioning according to Doppler sonography (84 patients)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional figure-of-four positioning (76 patients)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 9438893

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms/kg
Number of subjects: 122

Group type: COMPARATOR
Intervention: NaCl 0.9% (Control)
Number of subjects: 122
Study: 8215479

Group type: EXPERIMENTAL
Intervention: Granisetron (3.0 mg/body) with methylprednisolone sodium (750 mg/body)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Methylprednisolone sodium (750 mg/body) plus metoclopramide (46.7 mg/body on average) and domperidone (82.9 mg/body on average)
Number of subjects: 23
Study: 2485052

Group type: EXPERIMENTAL
Intervention: Lisinopril (LIS) 20-80 mg q.d., n = 10
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nifedipine (NIF) 20-40 mg b.i.d., n = 5
Number of subjects: 15
Study: 29369493

Group type: EXPERIMENTAL
Intervention: DV3316 (shield-triggered pen-injector)
Number of subjects: 150

Group type: COMPARATOR
Intervention: FlexPen (standard pen-injector)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: DV3316
Number of subjects: 150

Group type: COMPARATOR
Intervention: FlexPen
Number of subjects: 150
Study: 26842425

Group type: EXPERIMENTAL
Intervention: Structured, moderate intensity physical activity program (n=818) conducted in a center (twice a week) and at home (3‐4 times a week) including aerobic, strength, flexibility, and balance training activities.
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education program (n=817) consisting of workshops on topics relevant to older people and upper extremity stretching exercises.
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Structured physical activity program (men)
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education program (women)
Number of subjects: 1635
Study: 24504686

Group type: EXPERIMENTAL
Intervention: LY2605541 (0.01‐2.22 U/kg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Insulin glargine (0.5‐0.8 U/kg)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: LY2605541 (SC)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Insulin glargine (SC)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: LY2605541 (IV)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: LY2605541
Number of subjects: 41
Study: 22695363

Group type: EXPERIMENTAL
Intervention: Hand-held circular coil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Navigated figure-of-eight coil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Circular coil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All coil systems (with outlier removed)
Number of subjects: 10
Study: 20482960

Group type: EXPERIMENTAL
Intervention: Pharmacoeducation module
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 18507948

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with compressive plate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interlocking intramedullary nailing
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cannulated screws for femoral neck fractures
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Proximal femoral nail for fixing both neck and shaft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 20
Study: 15730350

Group type: EXPERIMENTAL
Intervention: Reserpine 0.5 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gabapentin 1800 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lamotrigine 150 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 14520213

Group type: EXPERIMENTAL
Intervention: Immediate removal of in‐dwelling catheter after operation
Number of subjects: 250

Group type: COMPARATOR
Intervention: In‐dwelling catheter removed on the first day after operation
Number of subjects: 250
Study: 10756218

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide 0.25 mg every 6 hours (group A)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nebulized ipratropium bromide 0.1 mg every 6 hours (group B)
Number of subjects: 71
Study: 9161235

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin (100 IU in 1 mL saline) administered three times per week for 3 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (1 mL saline) administered three times per week for 3 weeks
Number of subjects: 13
Study: 8339551

Group type: EXPERIMENTAL
Intervention: 20 mg oral simvastatin daily for 2 years
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo daily for 2 years
Number of subjects: 383
Study: 3485937

Group type: EXPERIMENTAL
Intervention: Esmolol (Group E)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Group S)
Number of subjects: 30
Study: 30189876

Group type: EXPERIMENTAL
Intervention: 21-day MPRRI program
Number of subjects: 388

Group type: COMPARATOR
Intervention: Waiting-list comparison (WLC)
Number of subjects: 388
Study: 24120718

Group type: EXPERIMENTAL
Intervention: i.v. sugammadex 4 mg/kg with oral aspirin 75 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: i.v. sugammadex 4 mg/kg
Number of subjects: 26

Group type: COMPARATOR
Intervention: i.v. placebo
Number of subjects: 26

Group type: COMPARATOR
Intervention: i.v. placebo/sugammadex
Number of subjects: 26
Study: 21418212

Group type: EXPERIMENTAL
Intervention: Hanen's 'More Than Words' (HMTW) intervention over 3.5 months
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Hanen's 'More Than Words' (HMTW) intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: 'Business as usual' control group
Number of subjects: 62
Study: 19344563

Group type: EXPERIMENTAL
Intervention: Sublingual ketorolac (30 mg, three doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV metamizole (1 g)
Number of subjects: 0
Study: 17368263

Group type: EXPERIMENTAL
Intervention: Newly developed laparoscopic morcellator
Number of subjects: 48

Group type: COMPARATOR
Intervention: Existing laparoscopic morcellator
Number of subjects: 48
Study: 15015612

Group type: EXPERIMENTAL
Intervention: sME HELIXOR A
Number of subjects: 224

Group type: COMPARATOR
Intervention: Lentinan (Control)
Number of subjects: 224
Study: 11292134

Group type: EXPERIMENTAL
Intervention: Employing a full-time data manager
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Employing a part-time data manager
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data manager responsible for data quality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shared responsibility for data quality
Number of subjects: 0
Study: 9764063

Group type: EXPERIMENTAL
Intervention: Empirical amiodarone
Number of subjects: 132

Group type: COMPARATOR
Intervention: Electrophysiologically guided treatment
Number of subjects: 132
Study: 8141445

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1.2 mg.h‐1) + Fentanyl (1.2 mg.h‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.6‐1.2 vol%) + Fentanyl (1.2 mg.h‐1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol (4‐8 mg.kg‐1.h‐1) + Fentanyl (1.2 mg.h‐1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 45
Study: 3290709

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Methylprednisolone and Azathioprine combination therapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 31021890

Group type: EXPERIMENTAL
Intervention: Split-dose preparation (4-L polyethylene glycol)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Same-day preparation (4-L polyethylene glycol)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Bowel preparation ≥7 hours before colonoscopy
Number of subjects: 300
Study: 28219104

Group type: EXPERIMENTAL
Intervention: Captopril (3×50 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Captopril and Placebo
Number of subjects: 12
Study: 26571023

Group type: EXPERIMENTAL
Intervention: Stress reduction with the Transcendental Meditation technique and a basic health education course (SR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Extensive health education program (EHE)
Number of subjects: 48
Study: 23142441

Group type: EXPERIMENTAL
Intervention: Single-injection femoral nerve block (FNB)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (FNB)
Number of subjects: 200
Study: 22017225

Group type: EXPERIMENTAL
Intervention: Beating Bipolar intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 50
Study: 18664541

Group type: EXPERIMENTAL
Intervention: 0.3 mg rhTSH
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 21514190

Group type: EXPERIMENTAL
Intervention: Yoga poses (Cobra, Cat, and Fish Poses)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study: 15910868

Group type: EXPERIMENTAL
Intervention: Molsidomine 16 mg once a day (o.a.d.)
Number of subjects: 172
Study: 11823268

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 157

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 157
Study: 9572791

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 7

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 7
Study: 8574301

Group type: EXPERIMENTAL
Intervention: Teachers of singing
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Dehydrating medications
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Past voice problem
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Younger subjects
Number of subjects: 174
Study: 2503020

Group type: EXPERIMENTAL
Intervention: Inhalation of 20 mg sodium cromoglycate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Deep inspiration at 4 hours
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 6
Study: 367509

Group type: EXPERIMENTAL
Intervention: 125 mg vancomycin six-hourly for five days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 29337426

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CYC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tacrolimus (TAC)
Number of subjects: 80
Study: 27576774

Group type: EXPERIMENTAL
Intervention: Continued thienopyridine therapy (75 to 325 mg aspirin daily)
Number of subjects: 11648

Group type: EXPERIMENTAL
Intervention: Continued thienopyridine therapy
Number of subjects: 11648

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 11648

Group type: COMPARATOR
Intervention: Stent thrombosis
Number of subjects: 11648

Group type: COMPARATOR
Intervention: Death
Number of subjects: 11648
Study: 24887576

Group type: EXPERIMENTAL
Intervention: Low-dose contrast medium (400 mgI/kg) with 80 kV(p)
Number of subjects: 63
Study: 22729169

Group type: EXPERIMENTAL
Intervention: Artificial pupil contact lens
Number of subjects: 22

Group type: COMPARATOR
Intervention: Monovision
Number of subjects: 22
Study: 19707728

Group type: EXPERIMENTAL
Intervention: 6-h Evidence Based Medicine (EBM) Workshop
Number of subjects: 0
Study: 18174489

Group type: EXPERIMENTAL
Intervention: Very Early Mobilization (VEM)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 71
Study: 16168039

Group type: EXPERIMENTAL
Intervention: Psychotherapy and antidepressants
Number of subjects: 257

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 257
Study: 13129987

Group type: EXPERIMENTAL
Intervention: Active bipolar magnets
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sham magnets
Number of subjects: 101
Study: 10456592

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (ear acupuncture)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 72
Study: 8754963

Group type: EXPERIMENTAL
Intervention: loratadine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate
Number of subjects: 60

Group type: COMPARATOR
Intervention: oxymetazoline
Number of subjects: 60
Study: 1817903

Group type: EXPERIMENTAL
Intervention: Articain
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Lidocain
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Unknown anesthetic solutions
Number of subjects: 1500
Study: 6983500

Group type: EXPERIMENTAL
Intervention: Trimethoprim (300 mg at night)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Co-trimoxazole (two tablets 12-hourly for seven days)
Number of subjects: 89
Study: 31442001

Group type: EXPERIMENTAL
Intervention: Intraoperative antibiotics prescribed by 95.0% of surgeons
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Postoperative antibiotics prescribed by 73.6% of respondents
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Factors influencing intraoperative antibiotic use
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Factors influencing postoperative antibiotic use
Number of subjects: 208
Study: 29085957

Group type: EXPERIMENTAL
Intervention: Immediate teriparatide therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Delayed teriparatide therapy
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 13
Study: 27060082

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis synovial fluid (SF)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Osteoarthritis synovial fluid (SF)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Comparison of citrullinated proteins
Number of subjects: 12

Group type: COMPARATOR
Intervention: Citrullinated histone H3.3 (H3F3A)
Number of subjects: 12
Study: 25567311

Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m² q3w (standard group)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cisplatin 80 mg/m² q3w (study group)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cisplatin 80 mg/m² q3w or 100 mg/m² q3w
Number of subjects: 88
Study: 22765322

Group type: EXPERIMENTAL
Intervention: Medication management augmented with emotionally focused therapy (MM + EFT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Medication management alone (MM)
Number of subjects: 24
Study: 20178543

Group type: EXPERIMENTAL
Intervention: Total laparoscopic hysterectomy using the Hohl instrument
Number of subjects: 257
Study: 18382805

Group type: EXPERIMENTAL
Intervention: BCG vaccine (1-3 doses with a one-month interval)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: BCG vaccine (for patients who failed to respond to placebo)
Number of subjects: 200
Study: 16152755

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Cotrimoxazole (stopped)
Number of subjects: 498
Study: 11850288

Group type: EXPERIMENTAL
Intervention: 600 mg telithromycin, once daily for 5 days (Group A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 600 mg telithromycin, once daily for 5 days (Group B)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 800 mg telithromycin, once daily for 5 days (Group C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 800 mg telithromycin, once daily for 5 days (Group D)
Number of subjects: 24
Study: 12047398

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 microg) administered during insulin clamp studies
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (without misoprostol) during insulin clamp studies
Number of subjects: 14
Study: 9583286

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels (374 +/- 11.9 mg/dL)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (non-ischaemic heart disease)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels > 300 mg percent
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Triple-vessel disease
Number of subjects: 131